Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

0.000p
   
  • Closing Price Chg:
      5.00p
  • 52 Week High: 2,715.00p
  • 52 Week Low: 1,424.00p
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 0
  • RiskGrade: 128
  • Beta: 1.30

London close: Stocks maintain gains after weak US payrolls

By Josh White

Date: Thursday 04 Sep 2025

LONDON (ShareCast) - (Sharecast News) - London stocks ended higher on Thursday as investors weighed weaker US labour market data against sector-specific losses in airlines.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,470.00p
Closing Price Change 5.00p
% Change 0.00 %
52 Week High 2,715.00p
52 Week Low 1,424.00p
Volume 0
Shares Issued 66.54m
Beta 1.30
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 06-Nov-2025

Time Volume / Share Price
12:23 4 @ 2,400.00p
12:23 36 @ 2,400.00p
12:23 12 @ 2,400.00p
12:23 127 @ 2,400.00p
12:23 147 @ 2,400.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page